References
- Ainsworth PD, Johnson MA (2010). The prognostic significance of the metastatic lymph node ratio in Dukes stage C colorectal cancer in a district general hospital. Colorectal Dis, 12, 1219-22. https://doi.org/10.1111/j.1463-1318.2009.02026.x
- Compton C, Fenoglio-Preiser CM, Pettigrew N, Fielding LP (2000). American joint committee on cancer prognostic factors consensus conference: colorectal working group. Cancer, 88, 1739-57. https://doi.org/10.1002/(SICI)1097-0142(20000401)88:7<1739::AID-CNCR30>3.0.CO;2-T
- Desnoyers LR, Pai R, Ferrando RE, et al (2008). Targeting FGF19 inhibits tumor growth in colon cancer xenograft and FGF19 transgenic hepatocellular carcinoma models. Oncogene, 27, 85-97. https://doi.org/10.1038/sj.onc.1210623
- Engstrom W, Granerus M (2006). Effects of fibroblast growth factors 19 and 20 on cell multiplication and locomotion in a human embryonal carcinoma cell line (Tera-2) in vitro. Anticancer Res, 26, 3307-10.
- Feng S, Dakhova O, Creighton CJ, Ittmann M (2013). Endocrine Fibroblast Growth Factor FGF19 Promotes Prostate Cancer Progression. Cancer Res, 73, 2551-62. https://doi.org/10.1158/0008-5472.CAN-12-4108
- French DM, Lin BC, Wang M, et al (2012). Targeting FGFR4 inhibits hepatocellular carcinoma in preclinical mouse models. PLoS One, 7, 36713. https://doi.org/10.1371/journal.pone.0036713
- Gout S, Huot J (2008). Role of cancer microenvironment in metastasis: focus on colon cancer. Cancer Microenviron. 1, 69-83. https://doi.org/10.1007/s12307-008-0007-2
- Hyeon J, Ahn S, Lee JJ, Song DH, Park CK (2013). Expression of Fibroblast Growth Factor 19 Is Associated with Recurrence and Poor Prognosis of Hepatocellular Carcinoma. Dig Dis Sci, [Epub ahead of print].
- Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90. https://doi.org/10.3322/caac.20107
- Johnson PM, Porter GA, Ricciardi R, Baxter NN (2006). Increasing negative lymph node count is independently associated with improved long-term survival in stage IIIB and IIIC colon cancer. J Clin Oncol, 24, 3570-5. https://doi.org/10.1200/JCO.2006.06.8866
- Karamitopoulou E, Zlobec I, Patsouris E, Peros G, Lugli A (2011). Loss of E-cadherin independently predicts the lymph node status in colorectal cancer. Pathology, 43, 133-7. https://doi.org/10.1097/PAT.0b013e3283425b7f
- Katoh M (2006). Cross-talk of WNT and FGF signaling pathways at GSK3beta to regulate beta-catenin and SNAIL signaling cascades. Cancer Biol Ther, 5, 1059-64. https://doi.org/10.4161/cbt.5.9.3151
- Lin BC, Desnoyers LR (2012). FGF19 and cancer. Adv Exp Med Biol, 728, 183-94. https://doi.org/10.1007/978-1-4614-0887-1_12
- Miyake A, Nakayama Y, Konishi M, Itoh N (2005). Fgf19 regulated by Hh signaling is required for zebrafish forebrain development. Dev Biol, 288, 259-75. https://doi.org/10.1016/j.ydbio.2005.09.042
- Nicholes K, Guillet S, Tomlinson E, et al (2002). A mouse model of hepatocellular carcinoma: ectopic expression of fibroblast growth factor 19 in skeletal muscle of transgenic mice. Am J Pathol, 160, 2295-307. https://doi.org/10.1016/S0002-9440(10)61177-7
- Ornitz DM (2005). FGF signaling in the developing endochondral skeleton. Cytokine Growth Factor Rev, 16, 205-13. https://doi.org/10.1016/j.cytogfr.2005.02.003
- Pai R, Dunlap D, Qing J, et al (2008). Inhibition of fibroblast growth factor 19 reduces tumor growth by modulating betacatenin signaling. Cancer Res, 68, 5086-95. https://doi.org/10.1158/0008-5472.CAN-07-2325
- Quirke P, Williams GT, Ectors N, et al (2007). The future of the TNM staging system in colorectal cancer: time for a debate? Lancet Oncol, 8, 651-7. https://doi.org/10.1016/S1470-2045(07)70205-X
- Rosenberg R, Friederichs J, Schuster T, et al (2008). Prognosis of patients with colorectal cancer is associated with lymph node ratio: a single-center analysis of 3,026 patients over a 25-year time period. Ann Surg, 248, 968-78. https://doi.org/10.1097/SLA.0b013e318190eddc
- Royston D, Jackson DG (2009). Mechanisms of lymphatic metastasis in human colorectal adenocarcinoma. J Pathol, 217, 608-19. https://doi.org/10.1002/path.2517
- Siffroi-Fernandez S, Felder-Schmittbuhl MP, Khanna H, Swaroop A, Hicks D (2008). FGF19 exhibits neuroprotective effects on adult mammalian photoreceptors in vitro. Invest Ophthalmol Vis Sci, 49, 1696-704. https://doi.org/10.1167/iovs.07-1272
- Wang J, Hassett JM, Dayton MT, Kulaylat MN (2008). Lymph node ratio: role in the staging of node-positive colon cancer. Ann Surg Oncol, 15, 1600-8. https://doi.org/10.1245/s10434-007-9716-x
- Wu X, Ge H, Lemon B, et al (2010). FGF19-induced hepatocyte proliferation is mediated through FGFR4 activation. J Biol Chem, 285, 5165-70. https://doi.org/10.1074/jbc.M109.068783
- Xie MH, Holcomb I, Deuel B, et al (1999). FGF-19, a novel fibroblast growth factor with unique specificity for FGFR4. Cytokine, 11, 729-35. https://doi.org/10.1006/cyto.1999.0485
Cited by
- Accuracy of Preoperative Urinary Symptoms, Urinalysis, Computed Tomography and Cystoscopic Findings for the Diagnosis of Urinary Bladder Invasion in Patients with Colorectal Cancer vol.15, pp.17, 2014, https://doi.org/10.7314/APJCP.2014.15.17.7241
- Baicalein inhibits the migration and invasion of colorectal cancer cells via suppression of the AKT signaling pathway vol.11, pp.1, 2016, https://doi.org/10.3892/ol.2015.3935